AGENUS
Live / Applied — Ex parte appeal pending (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 13 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97886578
- Mark type
- Stylized text
- Filed
- 13 Apr 2023
- Attorney of record
- CHRISTINA M LICURSI
Goods and services
- Class 001 — Chemicals: Biological preparations for scientific and research purposes; monoclonal antibodies for scientific and research purposes; antibodies for scientific and research purposes
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biologics for medical purposes, namely, biological preparations for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; monoclonal antibodies for medical purposes; antibodies for medical purposes; adjuvants for medical purposes; vaccines; cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease
- Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific research and development; medical research and development; pharmaceutical research and development in the fields of cancer, immunology, and immuno-oncology
Owner
- Agenus Inc., Lexington, MA, US
Prosecution history
- 15 Jan 2026 — EX PARTE APPEAL-INSTITUTED
- 15 Jan 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 04 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 04 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Jul 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 15 Jul 2025 — FINAL REFUSAL E-MAILED
- 15 Jul 2025 — FINAL REFUSAL WRITTEN
- 05 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2024 — NON-FINAL ACTION E-MAILED
- 05 Nov 2024 — NON-FINAL ACTION WRITTEN